Cargando…

Multiple cross displacement amplification-a more applicable technique in detecting Pseudomonas aeruginosa of ventilator-associated pneumonia (VAP)

BACKGROUND: Early and rapid identification of Pseudomonas aeruginosa (P. aeruginosa) in patients with suspected ventilator-associated pneumonia (VAP) provides theoretical clinical advantages in therapeutic optimization strategies. METHODS: The P. aeruginosa-multiple cross displacement amplification...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Juxiang, Chen, Huimin, Lin, Xiaomin, Ji, Chengyi, Chen, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276953/ https://www.ncbi.nlm.nih.gov/pubmed/32513206 http://dx.doi.org/10.1186/s13054-020-03003-4

Ejemplares similares

Use of a ventilator-associated pneumonia (VAP) bundle to decrease the VAP rate in Syria
por: Alsadat, R, et al.
Publicado: (2012)

The effect of lactulose in prevention of ventilator associated pneumonia (VAP)
por: Zvonicek, V, et al.
Publicado: (2001)

Surveillance tracheal aspirate in ventilator associated pneumonia (VAP)
por: Lampati, L, et al.
Publicado: (2001)

Pseudomonas aeruginosa ventilator-associated pneumonia management
por: Ramírez-Estrada, Sergio, et al.
Publicado: (2016)

Epidemiology of ventilator associated pneumonia (vap) in patients with abdominal sepsis
por: Hom Choudhuri, A, et al.
Publicado: (2015)

Pseudomonas aeruginosa colonization enhances ventilator-associated pneumonia-induced lung injury
por: Tsay, Tzyy-Bin, et al.
Publicado: (2016)

The zero-VAP sophistry and controversies surrounding prevention of ventilator-associated pneumonia
por: Colombo, Sebastiano Maria, et al.
Publicado: (2019)

The influence of enteral feeding on ventilator associated pneumonia (VAP) in trauma mechanically ventilated patients in ICU
por: Djazmati, W, et al.
Publicado: (2001)

Use of Adaptive Support Ventilation (ASV) in Ventilator Associated Pneumonia (VAP) - A Case Report
por: Kath, Bipphy, et al.
Publicado: (2009)

Ventilator-assisted priming of an anaesthesia circuit (VAP technique): An exploratory study
por: Ali, Muhammad S., et al.
Publicado: (2022)

Microbiological study of ventilator-associated pneumonia (VAP) after implantation of pneumonia program zero (NZ)
por: Fernández Fernández, R, et al.
Publicado: (2015)

Characterization of the virulence of Pseudomonas aeruginosa strains causing ventilator-associated pneumonia
por: Alonso, Beatriz, et al.
Publicado: (2020)

Pneumonia associated with mechanical ventilation (VAP): influence on morbidity and mortality in critically ill patients
por: Lucena, JG, et al.
Publicado: (2001)

Non-infectious approach to ventilator-associated pneumonia (VAP) in neonates: a new concept
por: Bejeh Mir, Karim Poorsattar, et al.
Publicado: (2012)

Above and beyond: biofilm and the ongoing search for strategies to reduce ventilator-associated pneumonia (VAP)
por: Sakano, Takashi, et al.
Publicado: (2020)

How healthcare must respond to ventilator-associated pneumonia (VAP) in invasively mechanically ventilated COVID-19 patients
por: Szarpak, Lukasz, et al.
Publicado: (2021)

ESKAPE bacteria characterization reveals the presence of Acinetobacter baumannii and Pseudomonas aeruginosa outbreaks in COVID-19/VAP patients
por: Loyola-Cruz, Miguel Ángel, et al.
Publicado: (2023)

Ventilator-associated pneumonia caused by Pseudomonas aeruginosa and respiratory colonization by Candida spp
por: Antonicelli, F, et al.
Publicado: (2010)

Correction to: Characterization of the virulence of Pseudomonas aeruginosa strains causing ventilator-associated pneumonia
por: Alonso, Beatriz, et al.
Publicado: (2020)

Identification of Potential Urinary Metabolite Biomarkers of Pseudomonas aeruginosa Ventilator-Associated Pneumonia
por: Jongers, Bart’s, et al.
Publicado: (2022)

Recurrent ventilator-associated pneumonia caused by “difficult to treat” resistance Pseudomonas aeruginosa
por: Rodríguez-Aguirregabiria, Montserrat, et al.
Publicado: (2022)

Monotherapy or combination antibiotic therapy in the treatment of Pseudomonas aeruginosa ventilator-associated pneumonia
por: Shen, Yanfei, et al.
Publicado: (2023)

ANTIBIOTIC SUSCEPTIBILITY PATTERNS OF DIFFERENT BACTERIA ISOLATED FROM PATIENTS WITH VENTILATOR ASSOCIATED PNEUMONIA (VAP)
por: Alqurashi, Abdulrahman M.
Publicado: (2005)

Diagnosis of Ventilator-Associated Respiratory Infections (VARI): Microbiologic Clues for Tracheobronchitis (VAT) and Pneumonia (VAP)
por: Craven, Donald E., et al.
Publicado: (2011)

Evolution ventilator associated pneumonia (VAP) in our intensive care unit, after pneumonia zero (PZ) program implementation
por: Fernández Fernández, R, et al.
Publicado: (2015)

Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa
por: Kaminski, Catherine, et al.
Publicado: (2011)

The rapid in vivo evolution of Pseudomonas aeruginosa in ventilator-associated pneumonia patients leads to attenuated virulence
por: Wang, Ke, et al.
Publicado: (2017)

Use of ventilator associated pneumonia bundle and statistical process control chart to decrease VAP rate in Syria
por: Alsadat, Reem, et al.
Publicado: (2012)

Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study
por: Erdem, Hakan, et al.
Publicado: (2019)

Microbial etiologies of ventilator-associated pneumonia (VAP) in intensive care unit of Beni-Suef University’s Hospital
por: Maebed, Al Zahraa M., et al.
Publicado: (2021)

The Impact of Care Bundles on Ventilator-Associated Pneumonia (VAP) Prevention in Adult ICUs: A Systematic Review
por: Mastrogianni, Maria, et al.
Publicado: (2023)

Duration of mechanical ventilation in trauma patients: risk factor for VAP?
por: Turriziani, I, et al.
Publicado: (2015)

1233 A Comparison of National Healthcare Safety Network (NHSN) Ventilator Associated Pneumonia (VAP) and Ventilator Associated Event (VAE) Definitions
por: Mcmullen, Kathleen, et al.
Publicado: (2014)

Protective ventilation reduces Pseudomonas aeruginosa growth in lung tissue in a porcine pneumonia model
por: Sperber, Jesper, et al.
Publicado: (2017)

Lower respiratory tract microbial composition was diversified in Pseudomonas aeruginosa ventilator-associated pneumonia patients
por: Qi, Xiaoling, et al.
Publicado: (2018)

Analysis of biofilm production by clinical isolates of Pseudomonas aeruginosa from patients with ventilator-associated pneumonia
por: Lima, Jailton Lobo da Costa, et al.
Publicado: (2017)

Rapid genetic and phenotypic changes in Pseudomonas aeruginosa clinical strains during ventilator-associated pneumonia
por: Persyn, Elise, et al.
Publicado: (2019)

1623. Outcomes of Critically Ill Adults, Hospitalized Patients (Pts) with Pseudomonas aeruginosa (PSA) Hospital- and Ventilator-Associated Pneumonia (HAP/VAP) Who Received an Active Anti-Pseudomonal β-Lactam (ASPB): Does “S” Equal Success in the Presence of Resistance to other ASPB?
por: Lodise, Thomas, et al.
Publicado: (2020)

Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID-19 or influenza
por: Laurichesse, Guillaume, et al.
Publicado: (2023)

Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia
por: Caffrey, Aisling R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qv8p09bk1lsa5ervkofbkbvvog